Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for VALTREX
- The Efficacy of Systemic Valacyclovir (Valtrex) on Periodontitis
- VZV in the Enteric Nervous System: Pathogenesis and Consequences
- Valacyclovir in Pain Management of Acute Apical Abscesses
- Valacyclovir for Mild Cognitive Impairment
- Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 2 Infection
- Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery
- A Phase 2, Muti-Center Study of Repeat Dosing of Squaric Acid Dibutyl Ester in Subjects With Herpes Labialis
- Anti-viral Therapy in Alzheimer's Disease
- Zoster Eye Disease Study
- Daylight Photodynamic Therapy for the Treatment of Actinic Keratoses in the Northeast United States
- Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic Leukemia
- A Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia
- A Study of Vacyless® Versus Valtrex® in Patients With Herpes Zoster
- ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation
- Special Drug Use Investigation for VALTREX (Valaciclovir) (Pediatrics Chickenpox)
- Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis)
- A Relative Bioavailability Study of Valacyclovir Hydrochloride Tablets 1gm Under Fasting Condition
- A Relative Bioavailability Study of Valacyclovir Hydrochloride Tablets 1gm Under Fed Condition
- Can Valacyclovir Attenuate Inflammation in Antiretroviral-Treated HIV-Infected Individuals With Herpes Simplex Virus Type 2?
- Valacyclovir 1000 mg Tablet Under Fasting Conditions
- Valacyclovir 1000 mg Tablet Under Fed Conditions
- Bioavailability Study of Valacycovir HCl Tablets, 1000 mg of Dr. Reddy's Under Fed Condition
- Bioavailability Study of Valacyclovir HCl Tablets, 1000 mg of Dr. Reddy's Under Fasting Conditions
- Cyclophosphamide, Fludarabine, Alemtuzumab, and Rituximab (CFAR) for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
- A Study of FV-100 Versus Valacyclovir in Patients With Herpes Zoster
- Study Comparing the Safety of ASP2151 to Valacyclovir and Placebo in Healthy Volunteers
- Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals?
- A Phase 2b Trial of EPB-348 for the Treatment of Herpes Zoster
- Identifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)
- Fed Study of Valacyclovir Hydrochloride Tablets 1000 mg and Valtrex® Tablets 1000 mg
- Fasting Study of Valacyclovir Hydrochloride Tablets 1000 mg and Valtrex® Tablets 1000 mg
- Food Study of Valacyclovir Hydrochloride Tablets 1000 mg to Valtrex® Tablets 1000 mg
- AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)
- Phase 2a Study of AdV-tk With Standard Radiation Therapy for Malignant Glioma (BrTK02)
- 30-Day Trial of Oral Valtrex or Valtrex Plus Aspirin on Shedding of HSV DNA in Tears and Saliva of Volunteers
- Oral Valganciclovir Versus Valacyclovir
- HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and Breastfeeding
- Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV
- CFAR Study in Patients With Chronic Lymphocytic Leukemia
- Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia
- HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons
- Research Study of Bipolar Mood Symptoms and Cognitive Problems
- Rituximab to the Preparative Regimen of Etoposide and Total Body Irradiation in Acute Lymphoblastic Leukemia
- Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma
- Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2
- Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes
- VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
- V3: Vancouver-Victoria Valacyclovir Trial for Early Psychosis
- A Study of Valacyclovir to Suppress HSV and HIV Shedding in Coinfected Persons
- A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies.
- VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies.
- Valacyclovir in Immunocompromised Children
- Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDS
- A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients
Clinical trials list
click for details